Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | ADRB2 | P07550 | 1/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
| ▸ | ADRB3 | P13945 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | SMPD1 | P17405 | 1/20 | 0.31 |
| ▸ | CES1 | P23141 | 1/20 | 0.31 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27854308 | 0.85 | — | — | |
| SCHEMBL6902239 | 0.82 | TSHR (0.33) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL20597461 | 0.80 | TSHR (0.39) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL851575 | 0.76 | TSHR (0.36) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL27705656 | 0.75 | TSHR (0.39) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL7066435 | 0.74 | CES1 (0.47) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL6049425 | 0.74 | TSHR (0.34) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL3117799 | 0.74 | TSHR (0.34) | TSHRADRB2ADRB1ADRB3ALDH1A1 | |
| SCHEMBL11567707 | 0.74 | — | — | |
| SCHEMBL11289886 | 0.74 | TSHR (0.42) | TSHRADRB2ADRB1ADRB3ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3515876-A1 | TWO-COMPONENT MORTAR MASS AND USE THEREOF | HILTI Aktiengesellschaft (LI) | 2019-07-31 | — | — | EP | disclosed |